NASDAQ: STIM Neuronetics, Inc. 10-K

Neuronetics revenue doubles to $149M on Greenbrook integration; CEO transition, covenant relief signal execution risk

Filed March 17, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 27, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade STIM commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.